avandia fda decision

Daily visits to selected websites, subscriptions to selected scientific and medical podcast as well as my monthly magazines such as Nature, Scientific American, Physics Today, Science Magazine and Science Readers. respirate just convinced me to add the FDA website into my dailies. What is good with technology these days is that you can be very selective regarding the kind of information you want to get and newspapers make me angry for some reasons that are totally personal.

See this link for FDA issued warnings on Actos and Avandia http://diabetes.niddk.nih.gov/dm/pubs/medicines_ez/insert_J.aspx Kinda makes you wonder if it's time to leave the sinking ship.

Also, Avandia is the other drug that falls into this classification. The FDA warns not to use Avandia for first time users, in fact, the FDA severely restricts its use. You can read about the different oral diabetes medication classifications and drugs that fall into each class here. http://tinyurl.com/type2-diabetes-drug-classes Always ask your doctor why he/she is Rx a drug vs others on the market.

org/wiki/Thiazolidinedione this drug is same family as Rosiglitazone (Avandia) which has been foud active on hbsag and hbvdna, question is does TZD lower hbsag since decrease of hbsag inibits cancer growth too and if lowered to und eradicate hbv?

She is gaining weight, has trouble breathing, and has been experiencing some chest pains lately (Dr. gave nitro). She is on avandia and I would like to know if this could be the cause of her recent decline in health?

I use Actos, but for some reason my fingers typed Avandia. Our FDA went through the same review on Avandia recently, and reluctantly left it on the shelf; however, it is used only when patients are found refractory to other, similar drugs, I believe. FlGuy, although I was down to 185 pounds at one point during treatment, I’m currently the lankiest 6’ 0” 250 pounder you’ve ever seen :o). I’ve always led an active lifestyle, so I don’t fit the sedentary profile of typical DM II patients.

Actos belongs in class of diabetes medications called thiazolidinediones. In this class are Avandia and a combination drug Avandamet [Avandia and Metformin]. Rezulin is in this class but not much known about it.

Also go on the websites of the manufactures, sometimes they have coupons for a % off your bill. When I joint the avandia program I got a couple months free avandia, plus they send coupons at times. Also ask your md for samples. I use to work at a doctors office and we got enough samples to open a pharmacy. Another thing, if your job offers a flexible spending account, I find that is nice as well. it reduces your taxes and you can contribute up to 3000 a year to them. good luck.

Yes, i was put on Avandia for Type 2 abt 5 years ago. Since then my #'s have improved with diet and exercise to the point that a new Dr. said she saw no reason for me to be on Avandia and i have since stopped useing it. It was never vy high, around 159 or so when it was diagnosed. If i am not careful of my diet it can jump up to the 130's to 140's. Am also on diovan for HBP which is usually under good control with the 1 med.

I have a chance to do a study trial with all oral drugs with a group of hepatologists at a hospital. It worries me that these drugs are not FDA approved and have never been used all together on humans before. Or I can do a study with the approved drugs with the same specialists. The all oral drugs they say have less side effects and its possibile to treats in 12 weeks. The approved drugs are longer and more side effects. The plus is that my treatment would all be free.

Can I take Evening Primrose and Femara together? I'm also taking Avandia. Any thoughts would be great!

My MD states that Telaprevir is going thru FDA studies now, and should be available by July 2011, my MD "thinks". This is being given along with peginterferon and ribavirin. FDA has accepted the NEW DRUG application. This is supposed to double viral cure rates. So I'm told..

Vertex said it stands ready to market hepatitis C drug telaprevir, under the brand name Incivek, and its approval could come as early as this month. They are ready to roll it out as soon as the fda approves it......

The government also said that GSK failed to report relevant safety information about the popular diabetes treatment Avandia to the FDA and even directly paid medical professionals to push the product on doctors for its alleged benefits for the heart -- even though GSK had no scientific data to back up that claim. In all, GSK pleaded guilty to three criminal charges for which it will pay $1 billion and another $2 billion will be paid in civil liabilities under the False Claims Act.

Metformin is in general, a good medication. There are others in the class such as Avandia. You can talk to your doctor about this. You might try drinking more water, eating more fiber (vegetables, whole grains), taking psyllium seed fiber and walking regularly. Each of those can help. Of course, there is always the laxative option but it's best to try the others first. Take it with meals, this helps. Onglyza is another alternative medication idea.

shutdown did not affect the timeline for approval. The PDUFA decision date for sofosbuvir is December 8 or 9 depending on where you look. The overall tone of this document is very encouraging for a swift approval. As a genotype 2 hoping for the all oral treatment ASAP this is very good news. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AntiviralDrugsAdvisoryCommittee/UCM371877.pdf?

In this case I do wish the FDA had approved Lemtrada, and left the final INFORMED decision up to the person with MS and their medical team. It makes little sense for Lemtrada to be approved elsewhere and not here.

If anybody is really interested in the FDA's decision making process, apparently they're going to webcast the discussion on June 10, from 8:00 a.m. EDT to 5:00 p.m. EDT. "To join the multiple sclerosis drug webcast on June 10, at 8 a.m. EDT, register at http://fdaac.com" http://www.medicalnewstoday.com/articles/191247.

The trial first has to be approved by the FDA which is likely to accept the recommendation of the Recombinant DNA Advisory Committee (RAC). The next meeting of the RAC is in June, when this proposed trial is likely to be discussed. Details of their decision will be available on http://oba.od.nih.gov/rdna_rac/rac_meetings.html#RAC2013 If recommended, Benitec will then apply to the FDA for an IND.

Avandia fda decision

Common Questions and Answers about Avandia fda decision

avandia